Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Applicants should be in their final year of submission and close to the award of their doctoral thesis. The funding is for the period post-thesis submission and pre-thesis defence. The most innovative propositions (pitches) presented will be selected and the respective DPhil/PhD candidates’ host departments will be provided with a pre-seed fellowship award to fund accelerated development of discovery research in the applicant's  first post-doctoral year. The funding is not to be used for the continuation of DPhil/PhD doctoral programs or for conventional post-doctoral funding. The application must clearly meet the EIT Health objectives outlined on their website.

Read the call document

FUNDING AVAILABLE

Successful applicants will receive EUR 10,000 - EUR25,000 towards the cost of accelerated development of their idea in their first post-doctoral year. Funding can be used to further evaluate or translate research ideas, part-fund a salary or prepare a case for seed funding. The funding is not meant for the continuation of DPhil/PhD programmess or for conventional postdoctoral funding (applicants requiring such funding are encouraged to explore other sources).

Awards will be made at three (3) levels:

  • Gold:  EUR 25,000
  • Silver:  EUR 15,000
  • Bronze:  EUR 10,000

Recipients of fellowships will be further supported by Oxford University Innovation for the duration of their fellowship. This will include help to assess the commercial potential of their results, to protect and manage the associated intellectual property, to identify the optimal route to commercialisation (e.g. license to an existing company versus spinning out a new company), to define what potential commercial partners expect in terms of proof of concept for a given technology, to secure follow on translational funding where needed to achieve proof of concept, and to identify, attract and secure  potential partners/investors to further develop and commercialise new healthcare technologies.